CERo Therapeutics Holdings Overview
- Year Founded
-
2016
- Status
-
Public
- Employees
-
8
- Stock Symbol
-
CERO
- Investments
-
1
CERo Therapeutics Holdings General Information
Description
CERo Therapeutics Holdings Inc is an immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. The company's molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.
Contact Information
Website
www.cero.bioCorporate Office
- 201 Haskins Way
- Suite 230
- South San Francisco, CA 94080
- United States
Corporate Office
- 201 Haskins Way
- Suite 230
- South San Francisco, CA 94080
- United States
CERo Therapeutics Holdings Timeline
CERo Therapeutics Holdings Stock Performance
As of 16-Nov-2026, CERo Therapeutics Holdings’s current market cap is $344K with 71.6M shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $344K | 71.6M | 583K | $40.34 |
CERo Therapeutics Holdings Financials Summary
As of 30-Jun-2026, CERo Therapeutics Holdings has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 7,455 | 9,020 | ||
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (14,353) | (18,846) | (6,311) | (10,898) |
| Net Income | (16,312) | (19,920) | (7,290) | (11,829) |
| Total Assets | 1,900 | 3,641 | 5,126 | 11,349 |
| Total Debt | 965 | 699 | 2,944 | 3,017 |
CERo Therapeutics Holdings Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CERo Therapeutics Holdings Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
CERo Therapeutics Holdings Comparisons
Industry
Financing
Details
CERo Therapeutics Holdings Competitors (4)
One of CERo Therapeutics Holdings’s 4 competitors is Eureka Therapeutics, a Venture Capital-Backed company based in Emeryville, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Eureka Therapeutics | Venture Capital-Backed | Emeryville, CA | ||||
| Bobcatbio | Venture Capital-Backed | Hummelstown, PA | ||||
| PDS Biotechnology | Formerly VC-backed | Princeton, NJ | ||||
| A2 Bio | Venture Capital-Backed | Agoura Hills, CA |
CERo Therapeutics Holdings Signals
CERo Therapeutics Holdings Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
CERo Therapeutics Holdings Acquisitions (1)
CERo Therapeutics Holdings’s most recent deal was a Merger/Acquisition with Phoenix Biotech Acquisition for . The deal was made on 14-Feb-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Phoenix Biotech Acquisition | 14-Feb-2024 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
CERo Therapeutics Holdings ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
CERo Therapeutics Holdings Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| CERo Therapeutics | South San Francisco, CA |
CERo Therapeutics Holdings FAQs
-
When was CERo Therapeutics Holdings founded?
CERo Therapeutics Holdings was founded in 2016.
-
Where is CERo Therapeutics Holdings headquartered?
CERo Therapeutics Holdings is headquartered in South San Francisco, CA.
-
What is the size of CERo Therapeutics Holdings?
CERo Therapeutics Holdings has 8 total employees.
-
What industry is CERo Therapeutics Holdings in?
CERo Therapeutics Holdings’s primary industry is Drug Discovery.
-
Is CERo Therapeutics Holdings a private or public company?
CERo Therapeutics Holdings is a Public company.
-
What is CERo Therapeutics Holdings’s stock symbol?
The ticker symbol for CERo Therapeutics Holdings is CERO.
-
What is the current market cap of CERo Therapeutics Holdings?
The current market capitalization of CERo Therapeutics Holdings is $344K.
-
Who are CERo Therapeutics Holdings’s competitors?
Eureka Therapeutics, Bobcatbio, PDS Biotechnology, and A2 Bio are competitors of CERo Therapeutics Holdings.
-
What is CERo Therapeutics Holdings’s annual earnings per share (EPS)?
CERo Therapeutics Holdings’s EPS for 12 months was $40.34.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process